NC

Narayan Chandra Debnath

Active Director Director DIN 10516508
DIN 10516508 First appointment May 2024 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Narayan Chandra Debnath

Data last updated:

Narayan Chandra Debnath is a Director at Iatrogenic Pharma Private Limited (since 2024). The company operates in Chemicals. Iatrogenic Pharma Private Limited reported revenue of ₹37.1 Lakh (FY 2025).

DIN 10516508
Primary Designation Director
Industry Chemicals
First Appointment 16 May 2024
Oldest Company Age 4 yrs
Largest company Iatrogenic Pharma Private Limited · ₹37.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Iatrogenic Pharma Private Limited U24246WB2022PTC253552
Director16 May 20242022₹37.1 Lakh (FY 2025)Active

Board colleagues of Narayan Chandra Debnath

Directorship timeline

Open interactive timeline →
Iatrogenic Pharma Private Limited
Premium access

Shareholding and investment profile for Narayan Chandra Debnath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Narayan Chandra Debnath

Narayan Chandra Debnath currently holds 1 directorship: Iatrogenic Pharma Private Limited (Director, since 16 May 2024, revenue ₹37.1 Lakh (FY 2025)).

Narayan Chandra Debnath was first appointed on 16 May 2024 as Director at Iatrogenic Pharma Private Limited.

The current boards of Narayan Chandra Debnath's companies include Dindayal Bhowmick (Iatrogenic Pharma Private Limited), Gopi Chandra Nath (Iatrogenic Pharma Private Limited), Suman Debnath (Iatrogenic Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available